Patents by Inventor Héléne Moussu

Héléne Moussu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers of immunotherapy efficacy
    Patent number: 10101341
    Abstract: The invention relates to proteins for use as markers for the efficacy of sublingual immunotherapy. In particular, the proteins may be used to predict the responsiveness of a patient to immunotherapy. The invention may find use in selecting patients as suitable candidates for immunotherapy.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: October 16, 2018
    Assignee: STALLERGENES
    Inventors: Véronique Bodo, Philippe Moingeon, Julien Bouley, Emmanuel Nony, Hélène Moussu, Karine Jain
  • BIOMARKERS OF IMMUNOTHERAPY EFFICACY
    Publication number: 20140112955
    Abstract: The invention relates to proteins for use as a marker for the efficacy of sublingual immunotherapy. In particular, the proteins may be used to predict the responsiveness of a patient to immunotherapy. The invention may find use in selecting patients as suitable candidates for immunotherapy.
    Type: Application
    Filed: April 6, 2012
    Publication date: April 24, 2014
    Applicant: STALLERGENES S.A.
    Inventors: Véronique Bodo, Philippe Moingeon, Julien Bouley, Emmanuel Nony, Héléne Moussu, Karine Jain